Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18006623rdf:typepubmed:Citationlld:pubmed
pubmed-article:18006623lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18006623lifeskim:mentionsumls-concept:C0018802lld:lifeskim
pubmed-article:18006623lifeskim:mentionsumls-concept:C0459523lld:lifeskim
pubmed-article:18006623lifeskim:mentionsumls-concept:C0037982lld:lifeskim
pubmed-article:18006623lifeskim:mentionsumls-concept:C0717550lld:lifeskim
pubmed-article:18006623lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:18006623lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:18006623lifeskim:mentionsumls-concept:C0600520lld:lifeskim
pubmed-article:18006623lifeskim:mentionsumls-concept:C0442796lld:lifeskim
pubmed-article:18006623pubmed:issue12lld:pubmed
pubmed-article:18006623pubmed:dateCreated2007-12-6lld:pubmed
pubmed-article:18006623pubmed:abstractTextThe activation of the renin-angiotensin-aldosterone system prevents the uptake of norepinephrine in the myocardium. However, the additive effects of combined spironolactone and candesartan on cardiac sympathetic nerve activity (CSNA) have not been determined. We investigated the effects of the angiotensin-receptor blocker candesartan alone and in combination with spironolactone on CSNA in patients with congestive heart failure (CHF).lld:pubmed
pubmed-article:18006623pubmed:languageenglld:pubmed
pubmed-article:18006623pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006623pubmed:citationSubsetIMlld:pubmed
pubmed-article:18006623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18006623pubmed:statusMEDLINElld:pubmed
pubmed-article:18006623pubmed:monthDeclld:pubmed
pubmed-article:18006623pubmed:issn0161-5505lld:pubmed
pubmed-article:18006623pubmed:authorpubmed-author:KurabayashiMa...lld:pubmed
pubmed-article:18006623pubmed:authorpubmed-author:SuzukiTadashi...lld:pubmed
pubmed-article:18006623pubmed:authorpubmed-author:SatoYuichiYlld:pubmed
pubmed-article:18006623pubmed:authorpubmed-author:SuminoHiroyuk...lld:pubmed
pubmed-article:18006623pubmed:authorpubmed-author:IchikawaShuic...lld:pubmed
pubmed-article:18006623pubmed:authorpubmed-author:KumakuraHisao...lld:pubmed
pubmed-article:18006623pubmed:authorpubmed-author:TakayamaYoshi...lld:pubmed
pubmed-article:18006623pubmed:authorpubmed-author:ToyamaTakujiTlld:pubmed
pubmed-article:18006623pubmed:authorpubmed-author:KasamaShuSlld:pubmed
pubmed-article:18006623pubmed:authorpubmed-author:MatsumotoNaoy...lld:pubmed
pubmed-article:18006623pubmed:issnTypePrintlld:pubmed
pubmed-article:18006623pubmed:volume48lld:pubmed
pubmed-article:18006623pubmed:ownerNLMlld:pubmed
pubmed-article:18006623pubmed:authorsCompleteYlld:pubmed
pubmed-article:18006623pubmed:pagination1993-2000lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:meshHeadingpubmed-meshheading:18006623...lld:pubmed
pubmed-article:18006623pubmed:year2007lld:pubmed
pubmed-article:18006623pubmed:articleTitleAdditive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.lld:pubmed
pubmed-article:18006623pubmed:affiliationDepartment of Cardiovascular Medicine, Gunma University School of Medicine, Maebashi, Japan. s-kasama@bay.wind.ne.jplld:pubmed
pubmed-article:18006623pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18006623pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18006623lld:pubmed